Article Details

Kisqali increases overall survival in advanced breast cancer patients by 12 months

Retrieved on: 2022-03-10 13:18:47

Tags for this article:

Click the tags to see associated articles and topics

Kisqali increases overall survival in advanced breast cancer patients by 12 months. View article details on HISWAI: https://www.europeanpharmaceuticalreview.com/news/169184/kisqali-longest-median-os-breast-cancer/

Excerpt

Further sub-analyses from these data will be shared with the scientific community later this year. Related topics. Anti-Cancer Therapeutics, Clinical ...

Article found on: www.europeanpharmaceuticalreview.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up